Skip to main content

Prescription medicine

Technetium tc 99m pyrophosphate

Technetium tc 99m pyrophosphate is a prescription medicine. No generic is listed in FDA's NDC Directory.

  • No generic listed
  • In shortage

Check it at the source: the technetium tc 99m pyrophosphate FDA label on DailyMed (effective March 11, 2025); every technetium tc 99m pyrophosphate label on DailyMed.

Highlights of the record

FDA label of March 11, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

Technetium Tc 99m Pyrophosphate Injection is a bone imaging agent used to demonstrate areas of altered osteogenesis, and a cardiac imaging agent used as an adjunct in the diagnosis of acute myocardial infarction.

Forms and strengths

  • 12 mg/10ml

Injection.

On the market

Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
2 of 2 presentations limited or unavailable updated September 18, 2026
Recalls by its makers (FDA)
No recall recorded
FAERS reports
4 through July 30, 2026

What is technetium tc 99m pyrophosphate used for?

From the label: indications and usage

Technetium Tc 99m Pyrophosphate Injection is a bone imaging agent used to demonstrate areas of altered osteogenesis, and a cardiac imaging agent used as an adjunct in the diagnosis of acute myocardial infarction. Kit for the Preparation of Technetium Tc 99m Pyrophosphate Injection is a blood pool imaging agent which may be used for gated blood pool imaging and for the detection of sites of gastrointestinal bleeding. When reconstituted with sterile non-pyrogenic isotonic saline and administered intravenously 30 minutes prior to the intravenous administration of Sodium Pertechnetate Tc 99m Injection, approximately 76% of the injected radioactivity remains in the blood pool.

FDA pharmacologic class: Radioactive Diagnostic Agent.

Source: FDA drug label (Kit for the Preparation of Technetium Tc99m Pyrophosphate), Sun Pharmaceutical Industries, Inc., effective March 11, 2025 (SPL set 1f0cbd23-2fb3-43b7-b8af-7de246151149), via openFDA; the full label on DailyMed

Is there a generic for technetium tc 99m pyrophosphate?

No generic technetium tc 99m pyrophosphate is approved (Drugs@FDA, October 8, 2026).

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

Is technetium tc 99m pyrophosphate in shortage?

The FDA Drug Shortage Database lists 2 of 2 technetium tc 99m pyrophosphate presentations as limited or unavailable (updated September 18, 2026); the first entry was posted on December 27, 2023.

PresentationCompanyStatusUpdated
CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1)Sun Pharmaceutical Industries, Inc.CurrentSeptember 18, 2026
CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-2)Sun Pharmaceutical Industries, Inc.CurrentSeptember 18, 2026

Every technetium tc 99m pyrophosphate presentation in the FDA shortage database

Source: FDA Drug Shortage Database via openFDA, updated October 8, 2026

What does the technetium tc 99m pyrophosphate label say about other medicines?

The technetium tc 99m pyrophosphate label names 1 other medicine in its interaction, contraindication or warning sections. The labels of 1 other medicine name technetium tc 99m pyrophosphate. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Tetrakis copper tetrafluoroboratewarningsAlternately, a brain imaging agent such as Technetium Tc 99m Pentetate Injection may be employed.

Check technetium tc 99m pyrophosphate against other medicines

Source: FDA drug label (Kit for the Preparation of Technetium Tc99m Pyrophosphate), Sun Pharmaceutical Industries, Inc., effective March 11, 2025 (SPL set 1f0cbd23-2fb3-43b7-b8af-7de246151149), via openFDA; the full label on DailyMed

What do FAERS reports show for technetium tc 99m pyrophosphate?

The FDA Adverse Event Reporting System holds 4 reports that list technetium tc 99m pyrophosphate among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 1 are coded as a death and 0 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Abdominal Distension1
  • Condition Aggravated (a use or a product term, not a reaction)1
  • Drug Level Changed1
  • Dyspnoea1
  • Flushing1
  • Headache1
  • Jaundice1
  • Pain1

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Other radioactive diagnostic agents
the pharmacologic class, with prices and generics
Technetium tc 99m pyrophosphate side effects
the label's list beside FAERS reports
Technetium tc 99m pyrophosphate shortage record
every presentation, company and date
Check an interaction
what two or more labels say about each other